Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT05076513
What this trial is testing

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+3 more
Nader Sanai 42
Testing effectiveness (Phase 2)UnknownNCT02663440
What this trial is testing

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Zhejiang Cancer Hospital 41
Testing effectiveness (Phase 2)UnknownNCT02137759
What this trial is testing

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Who this might be right for
Glioblastoma Multiforme of Brain
Emory University 29
Testing effectiveness (Phase 2)Looking for participantsNCT07185880
What this trial is testing

The Safety and Tolerability of MT-125 in GBM Patients

Who this might be right for
Glioblastoma (GBM)
Myosin Therapeutics Inc. 36
Early research (Phase 1)Study completedNCT02311920
What this trial is testing

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GliosarcomaSupratentorial Glioblastoma
National Cancer Institute (NCI) 32
Early research (Phase 1)Ended earlyNCT02254954
What this trial is testing

Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Actelion 30
Testing effectiveness (Phase 2)Ended earlyNCT00005856
What this trial is testing

Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 59
Not applicableStudy completedNCT00253669
What this trial is testing

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System TumorsThromboembolism
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 110
Testing effectiveness (Phase 2)Looking for participantsNCT07225621
What this trial is testing

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGBM
Alpheus Medical, Inc. 103
Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00110032
What this trial is testing

Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+24 more
National Cancer Institute (NCI) 46
Very early researchActive Not RecruitingNCT03893487
What this trial is testing

Fimepinostat in Treating Brain Tumors in Children and Young Adults

Who this might be right for
Diffuse Intrinsic Pontine GliomaRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma+2 more
Sabine Mueller, MD, PhD 30
Very early researchLooking for participantsNCT07284069
What this trial is testing

Senicapoc and Perampanel for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Aarhus University Hospital 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06157541
What this trial is testing

T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IV
Queensland Institute of Medical Research 58
Early research (Phase 1)Active Not RecruitingNCT03749187
What this trial is testing

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Who this might be right for
GlioblastomaIDH1 Gene MutationIDH2 Gene Mutation+7 more
University of California, San Francisco 78
Not applicableUnknownNCT05515133
What this trial is testing

Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma
Henan Provincial People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00187486
What this trial is testing

Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliosarcoma
University of California, San Francisco 66
Testing effectiveness (Phase 2)Study completedNCT00003456
What this trial is testing

Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme of Brain
Burzynski Research Institute 40
Early research (Phase 1)Study completedNCT05376800
What this trial is testing

Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

Who this might be right for
Glioblastoma
Boehringer Ingelheim 24
Early research (Phase 1)Study completedNCT03619239
What this trial is testing

Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma

Who this might be right for
Newly Diagnosed Glioblastoma
Genexine, Inc. 15
Next Page